Paeds SAQs · genetics-dysmorphology-and-metabolism
Urea cycle disorders and hyperammonaemia — formative SAQs
Formative SAQs on recognising hyperammonaemia as a metabolic emergency, localising the urea cycle defect with plasma amino acids and urinary orotic acid, delivering the acute 'treat on suspicion' protocol, and locking in long-term medical and transplant-based management.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A term male infant is well at birth but at 48 hours of age becomes lethargic, feeds poorly, vomits, and is found hyperventilating with a respiratory rate of 80. Blood gas shows a respiratory alkalosis. Sepsis cultures are pending. A bedside clinician sends an ammonia, which returns at 620 micromoles per litre. [1] [4]
a) Explain why this picture of a well neonate deteriorating 24 to 72 hours into feeds with a respiratory alkalosis is a classic urea cycle disorder presentation, and list the four immediate resuscitation moves you make. (3 marks) [1] [4]
b) Describe the first-tier metabolic panel you order to localise the defect, and explain how plasma amino acids and urinary orotic acid distinguish ornithine transcarbamylase deficiency from carbamoyl phosphate synthetase 1 and NAGS deficiency. (3 marks) [1]
c) Outline the role of nitrogen scavengers, arginine, and extracorporeal removal in this child, including the ammonia thresholds that would prompt dialysis. (2 marks) [5]
d) Discuss the prognostic significance of the peak ammonia and time to treatment, and the implications for counselling this family. (2 marks) [6]
References5ShowHide
- [1]Häberle J, Burlina A, Chakrapani A, Dixon M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis, 2019.PMID 30982989
- [4]Alfadhel M, Mutairi FA, Makhseed N, et al. Guidelines for acute management of hyperammonemia in the Middle East region. Ther Clin Risk Manag, 2016.PMID 27099506
- [5]Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, et al. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol, 2020.PMID 32269302
- [6]Kido J, Matsumoto S, Häberle J, et al. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan. J Inherit Metab Dis, 2021.PMID 33840128
- [8]Sin YY, Baron G, Schulze A, Funk CD. Arginase-1 deficiency. J Mol Med (Berl), 2015.PMID 26467175